Mesoblast Ltd (MESO)
7.35
+0.33
(+4.70%)
USD |
NASDAQ |
May 17, 16:00
7.36
+0.01
(+0.14%)
After-Hours: 20:00
Mesoblast Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 877.04M |
May 16, 2024 | 839.40M |
May 15, 2024 | 859.93M |
May 14, 2024 | 859.93M |
May 13, 2024 | 834.84M |
May 10, 2024 | 878.18M |
May 09, 2024 | 856.51M |
May 08, 2024 | 904.42M |
May 07, 2024 | 946.05M |
May 06, 2024 | 952.33M |
May 03, 2024 | 894.15M |
May 02, 2024 | 870.20M |
May 01, 2024 | 861.07M |
April 30, 2024 | 791.49M |
April 29, 2024 | 848.52M |
April 26, 2024 | 750.42M |
April 25, 2024 | 740.16M |
April 24, 2024 | 748.14M |
April 23, 2024 | 723.05M |
April 22, 2024 | 669.43M |
April 19, 2024 | 632.93M |
April 18, 2024 | 621.52M |
April 17, 2024 | 610.11M |
April 16, 2024 | 573.61M |
April 15, 2024 | 628.37M |
Date | Value |
---|---|
April 12, 2024 | 651.18M |
April 11, 2024 | 692.25M |
April 10, 2024 | 700.23M |
April 09, 2024 | 705.93M |
April 08, 2024 | 676.93M |
April 05, 2024 | 627.20M |
April 04, 2024 | 636.33M |
April 03, 2024 | 679.97M |
April 02, 2024 | 707.37M |
April 01, 2024 | 655.62M |
March 28, 2024 | 547.03M |
March 27, 2024 | 392.78M |
March 26, 2024 | 437.43M |
March 25, 2024 | 261.87M |
March 22, 2024 | 257.81M |
March 21, 2024 | 267.96M |
March 20, 2024 | 273.04M |
March 19, 2024 | 271.01M |
March 18, 2024 | 273.04M |
March 15, 2024 | 285.21M |
March 14, 2024 | 286.23M |
March 13, 2024 | 286.23M |
March 12, 2024 | 308.55M |
March 11, 2024 | 308.55M |
March 08, 2024 | 256.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
209.46M
Minimum
Dec 11 2023
2.403B
Maximum
Aug 17 2020
783.15M
Average
674.12M
Median
Jun 07 2023
Enterprise Value Benchmarks
Immuron Ltd | 2.026M |
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 5.257M |
Immutep Ltd | -- |
Opthea Ltd | 125.45M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -21.92M |
Revenue (Quarterly) | 2.139M |
Total Expenses (Quarterly) | 20.88M |
EPS Diluted (Quarterly) | 77.55 |